Importantly, tumour types which are not commonly ALT-positive (where ATRX mutation is a random passenger event) did not show a correlation between ATRX loss and decreased DRG2 expression, supporting a causal role for DRG2 in ALT tumorigenesis. The gene discussed is DRG2; the disease is neoplasm.